GALWAY, IRELAND--March 5, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--One of Japan's leading pharmaceutical companies, Daiichi Sankyo Propharma Company Limited has unveiled a 1 billion euro (US$1.09 billion) investment to expand its drug making operations in Germany.

Within this article: Details investment, timeline, company's push into cancer treatment sector, leading drugs in development, major deals with other players.

Login to Read More